2-Methylpiperazine structure
|
Common Name | 2-Methylpiperazine | ||
|---|---|---|---|---|
| CAS Number | 109-07-9 | Molecular Weight | 100.162 | |
| Density | 0.8±0.1 g/cm3 | Boiling Point | 153.2±8.0 °C at 760 mmHg | |
| Molecular Formula | C5H12N2 | Melting Point | 61-63 °C(lit.) | |
| MSDS | Chinese USA | Flash Point | 45.1±10.2 °C | |
| Symbol |
GHS02, GHS07 |
Signal Word | Danger | |
| Name | 2-Methylpiperazine |
|---|---|
| Synonym | More Synonyms |
| Density | 0.8±0.1 g/cm3 |
|---|---|
| Boiling Point | 153.2±8.0 °C at 760 mmHg |
| Melting Point | 61-63 °C(lit.) |
| Molecular Formula | C5H12N2 |
| Molecular Weight | 100.162 |
| Flash Point | 45.1±10.2 °C |
| Exact Mass | 100.100044 |
| PSA | 24.06000 |
| LogP | -0.68 |
| Vapour Pressure | 3.4±0.3 mmHg at 25°C |
| Index of Refraction | 1.418 |
| Storage condition | Flammables area |
| Water Solubility | 78 g/100 mL (25 ºC) |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS02, GHS07 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H228-H315-H319-H335 |
| Precautionary Statements | P210-P261-P305 + P351 + P338 |
| Personal Protective Equipment | Eyeshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
| Hazard Codes | F:Flammable |
| Risk Phrases | R11;R36/37/38 |
| Safety Phrases | S16-S26-S36/37/39 |
| RIDADR | UN 1325 4.1/PG 2 |
| WGK Germany | 2 |
| RTECS | TM1225020 |
| Packaging Group | III |
| Hazard Class | 4.1 |
| HS Code | 2933599090 |
| Precursor 9 | |
|---|---|
| DownStream 9 | |
| HS Code | 2933599090 |
|---|---|
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Induction of human leukemia cell differentiation via PKC/MAPK pathways by arsantin, a sesquiterpene lactone from Artemisia santolina.
Arch. Pharm. Res. 38 , 2020-8, (2015) Sesquiterpene lactone compounds have received considerable attention in pharmacological research due to their therapeutic effects including anti-cancer and anti-inflammatory activities. In this report... |
| 2-methyl-piperazin |
| Piperazine, 2-methyl- |
| 2-Methylpiperazine |
| EINECS 203-644-2 |
| Piperazine, 2-methyl-, (2S)- |
| PIPERAZINE,2-METHYL- |
| 2-METHYLPIPERAZINE/LOMEFLOXCIN |
| 2-METHYLPIPERAZIN |
| (rac)-2-methylpiperazine |
| UNII:D0LWN1061P |
| (S)-(+)-2-Methylpiperazine |
| 2-METHYLDIETHYLENEDIAMINE |
| 2-METHYL-PIPERAZINE |
| 2-methyl Piperazine |
| (+/-)-2-METHYLPIPERAZINE |
| 2MPRZ |
| (R,S)-2-methylpiperazine |
| (2S)-2-Methylpiperazine |
| (2R)-2-methylpiperazine |
| MFCD00005954 |
| 2-METHYLPIPERAZINE FOR SYNTHESIS |
| 2-(R,S)-methylpiperazine |